ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 84 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,638 | -62.9% | 35,092 | -46.5% | 0.00% | – |
| Q3 2021 | $142,000 | -68.5% | 65,591 | -49.2% | 0.00% | -100.0% |
| Q2 2021 | $451,000 | -7.2% | 128,991 | +161.7% | 0.00% | 0.0% |
| Q1 2021 | $486,000 | -67.1% | 49,297 | -63.9% | 0.00% | -66.7% |
| Q4 2020 | $1,479,000 | +0.3% | 136,423 | -4.7% | 0.01% | 0.0% |
| Q3 2020 | $1,474,000 | +629.7% | 143,123 | +271.7% | 0.01% | +500.0% |
| Q1 2019 | $202,000 | -88.2% | 38,506 | -92.9% | 0.00% | -87.5% |
| Q4 2018 | $1,710,000 | -49.8% | 542,893 | -3.6% | 0.01% | -33.3% |
| Q3 2018 | $3,406,000 | -28.2% | 562,893 | -37.1% | 0.01% | -40.0% |
| Q2 2018 | $4,745,000 | -37.4% | 895,249 | -31.5% | 0.02% | -42.9% |
| Q1 2018 | $7,575,000 | – | 1,306,048 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 6,552,068 | $14,218,000 | 8.03% |
| Versant Venture Management, LLC | 5,068,233 | $10,998,000 | 4.55% |
| K2 PRINCIPAL FUND, L.P. | 1,653,874 | $3,589,000 | 0.29% |
| RTW INVESTMENTS, LP | 7,483,757 | $16,240,000 | 0.24% |
| Avoro Capital Advisors LLC | 6,950,000 | $15,082,000 | 0.24% |
| Artal Group S.A. | 3,000,000 | $6,510,000 | 0.15% |
| ALGERT GLOBAL LLC | 231,490 | $502,000 | 0.07% |
| Virtus ETF Advisers LLC | 57,768 | $125,000 | 0.06% |
| Pinz Capital Management, LP | 53,600 | $116,000 | 0.05% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 100,000 | $217,000 | 0.05% |